The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration's Adverse Event Reporting System. - Alsuhaibani DS; Edrees HH; Alshammari TM (Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2023)